Posted byOrthoEx Posted in
Posted on May 10, 2018

AUDUBON, Pa., May 10, 2018 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, announced today it is sponsoring the Society of Lateral Access Surgery’s (SOLAS®) newly developed Partnership Program as that organization’s first corporate Alliance Partner.  SOLAS® is a non-profit organization that strives to shape the future of lateral access spine surgery through collaboration among members, exchange of ideas, and the promotion of new techniques that benefit patients, physicians and hospitals.  This sponsorship demonstrates Globus Medical’s commitment to supporting key educational and research initiatives important to advancing lateral access surgery.

“Globus Medical recognizes that SOLAS® is the largest surgeon organization focused primarily on advancing lateral access surgery through peer-to-peer interaction and clinical research”, said Andrew Iott, Senior Vice President Global Product Development. “As leaders in the musculoskeletal device industry, Globus Medical supports medical advancements in this area of spine surgery and recognizes its importance in improving patients’ lives.”

Globus Medical will attend the 11th Annual SOLAS® Meeting being held May 17-19 in San Diego as a Corporate Alliance Partner at the Fairmont Grand Del Mar. Globus representatives will showcase their comprehensive lateral implant and instrument solutions including seven different expandable lateral interbody fusion devices that allow for minimized insertion, continuous expansion, and an optimized fit for each patient.

“This is an excellent opportunity to engage with clinical thought leaders and highlight some of the latest advancements Globus has made with our lateral expandable devices”, said Mr. Iott. “The adjustable lordosis spacer options for the RISE-L® and ELSA® expandable spacer systems have received excellent feedback. We are excited to share how this technology can help surgeons maximize correction and address sagittal spinal imbalance from a lateral approach.”

Globus Medical invites meeting attendees to their exhibit space to experience its most recent product innovations and discuss future lateral advancements with the company’s product development experts.

To learn more about the Globus full line of lateral expandable spacers, visit

About Globus Medical, Inc.

Globus Medical, Inc. is a leading musculoskeletal solutions company based in Audubon, PA. The company was founded in 2003 by an experienced team of professionals with a shared vision to create products that enable surgeons to promote healing in patients with musculoskeletal disorders. Additional information can be accessed at

Safe Harbor Statements
All statements included in this press release other than statements of historical fact are forward-looking statements and may be identified by their use of words such as “believe,” “may,” “might,” “could,” “will,” “aim,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “plan” and other similar terms. These forward-looking statements are based on our current assumptions, expectations and estimates of future events and trends. Forward-looking statements are only predictions and are subject to many risks, uncertainties and other factors that may affect our businesses and operations and could cause actual results to differ materially from those predicted. These risks and uncertainties include, but are not limited to, factors affecting our quarterly results, our ability to manage our growth, our ability to sustain our profitability, demand for our products, our ability to compete successfully (including without limitation our ability to convince surgeons to use our products and our ability to attract and retain sales and other personnel), our ability to rapidly develop and introduce new products, our ability to develop and execute on successful business strategies, our ability to comply with changing laws and regulations that are applicable to our businesses, our ability to safeguard our intellectual property, our success in defending legal proceedings brought against us, trends in the medical device industry, general economic conditions, and other risks. For a discussion of these and other risks, uncertainties and other factors that could affect our results, you should refer to the disclosure contained in our most recent annual report on Form 10-K filed with the Securities and Exchange Commission, including the sections labeled “Risk Factors” and “Cautionary Note Concerning Forward-Looking Statements,” and in our Forms 10-Q, Forms 8-K and other filings with the Securities and Exchange Commission. These documents are available at Moreover, we operate in an evolving environment. New risk factors and uncertainties emerge from time to time and it is not possible for us to predict all risk factors and uncertainties, nor can we assess the impact of all factors on its business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on any forward-looking statements. Forward-looking statements contained in this press release speak only as of the date of this press release. We undertake no obligation to update any forward-looking statements as a result of new information, events or circumstances or other factors arising or coming to our attention after the date hereof.

Brian Kearns
Vice President, Business Development and Investor Relations
Phone: (610) 930-1800